ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0272

Calcifications of the Transverse Ligament of the Atlas in Patients Diagnosed with Calciumpyrophosphate Crystal Arthritis – a Retrospective Observational Study

Shay Brikman1, Noga Shabshin2 and Amir Bieber3, 1Emek Medical Center, Afula, Israel, 2Emek Medical Center, Clalit Health Services, Afula, Israel, 3Emek Medical Center, Clalit Health Services, Raanana, Israel

Meeting: ACR Convergence 2024

Keywords: CPPD, Crystal-induced arthritis, Imaging

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Chondrocalcinosis (CC) is commonly detected on
X-ray films of the knee, wrist, and symphysis pubis. Calcium pyrophosphate (CPP) deposition disease is sometimes associated with calcifications of the transverse ligament of the atlas (surrounding the odontoid process or periodontoid calcifications) and in rare occasions may manifest as an acute synovitis affecting the area involved (Crowned dense syndrome). In this study, we aimed to assess the presence of periodontoid calcifications (in the transverse ligament of the atlas) seen on cervical computed tomography (CT) scans of patients diagnosed with CPP arthritis.

Methods: A retrospective analysis was conducted assessing available cervical CT scans which were analyzed for periodontoid calcifications in one academic medical center during 2013-2023. All patients included were older than 60 years. Diagnosis of CPP crystal arthritis was considered if the patient had at least one previous acute synovitis with synovial fluid CPP crystals or CC on imaging and no other rheumatic inflammatory disease (such as gout or rheumatoid arthritis).
A review of cervical CT scans for periodontoid calcifications was performed by 2 independent (rheumatologists) observers. The presence of periodontoid calcifications was also assessed among a random sample of patients with either osteoarthritis (OA) or who suffered prior stroke, matched by age and gender (1:1) and serving as a control group. The frequency of periodontoid calcifications was compared between the CPP and the control groups. Sensitivity, specificity, and positive likelihood ratio (LR) for CPP based on the detection of periodontoid calcifications were calculated.

Results: 72 patients were included in both the CPP crystal arthritis group and the control group. Periodontoid calcifications were seen in 57 patients in the CPP group and only in 4 patients in the control group (79.2% vs 5.6% respectively), which was significantly higher (Yates’ correction for X2=76.9, P< 0.00001). According to our analysis, adding the presence of periodontoid calcifications on cervical CT in patients older than 60 years who are suspected of having CPP crystal arthritis (CC seen in the involved joint and not better explained by another inflammatory condition), may increase the sensitivity and specificity to 0.79 and 0.94 respectively. The positive LR was found to be 14.25.

Conclusion: Periodontoid calcifications seen on cervical CT were detected at a significantly higher frequency in patients with CPP crystal arthritis than in controls.
It is suggested that periodontoid calcifications may serve as another site for detecting CC (Knee, Wrist) when cervical CT is available for review.

Supporting image 1

Periodontoid calcifications as seen on cervical CT in one of the CPP arthritis patients


Disclosures: S. Brikman: AbbVie/Abbott, 1, Pfizer, 12, Support for registering ACR/EULAR meeting; N. Shabshin: Nanox Imaging, 2; A. Bieber: AbbVie/Abbott, 1, AstraZeneca, 1, Eli Lilly, 1, Novartis, 1.

To cite this abstract in AMA style:

Brikman S, Shabshin N, Bieber A. Calcifications of the Transverse Ligament of the Atlas in Patients Diagnosed with Calciumpyrophosphate Crystal Arthritis – a Retrospective Observational Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/calcifications-of-the-transverse-ligament-of-the-atlas-in-patients-diagnosed-with-calciumpyrophosphate-crystal-arthritis-a-retrospective-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/calcifications-of-the-transverse-ligament-of-the-atlas-in-patients-diagnosed-with-calciumpyrophosphate-crystal-arthritis-a-retrospective-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology